EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieValidierungsstudieOpen Access · CC BY 4.0

Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire

Vijayabharathy Kanthasamy, Richard J Schilling, Sarah Horan, Victoria Baker, Nikhil Ahluwalia, Ross J Hunter, Shohreh Honarbakhsh, Malcolm Finlay

Heart Rhythm · 2025-08 · 22 (8) · 1922-1934

DOI: 10.1016/j.hrthm.2025.02.007 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Heart Rhythm, 2025-08. Verfasst von Vijayabharathy Kanthasamy und 7 weiteren Autor:innen. Beteiligte Einrichtung: St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; William Harvey Research Institute, Queen Mary University of London, London…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Quality of Life, Patient Reported Outcome Measures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atrial fibrillation (AF) significantly affects patients' health-related quality of life (HRQoL), influencing physical, psychological, and social wellbeing. Despite existing tools, there is a notable lack of AF-specific instruments that comprehensively assess HRQoL and are developed in collaboration with patients from the outset. OBJECTIVE: This study aimed to develop and validate the AF specific Patient Reported Outcome Measures questionnaire (AF-PROMs), a novel, patient-centered tool designed to measure HRQoL in patients with AF. METHODS: A prospective, observational study was conducted across 2 centers in the United Kingdom, enrolling 856 participants (265 in the pilot phase, 550 in the field-validation phase). Item generation and domain selection were guided by extensive patient and public involvement (PPI), through focus groups and qualitative interviews with patients, ensuring content validity. Psychometric evaluations included exploratory (EFA) and confirmatory factor analyses (CFA), along with assessments of reliability, responsiveness, and known-group validity. RESULTS: The AF-PROMs tool demonstrated excellent internal consistency across all domains (Cronbach's alpha ≥0.89) and strong test-retest reliability (intraclass correlation coefficient [ICC] >0.97), highlighting its stability. The tool showed robust responsiveness to clinical changes, particularly post-catheter ablation, with moderate to large effect sizes (Cohen's d ≥1.0 for overall score), underscoring its sensitivity to meaningful treatment effects. The 3-factor model achieved a satisfactory fit. Known-group validity was confirmed by significant score differences (P < .01) between healthy volunteers and patients with AF across all domains. CONCLUSION: AF-PROMs is a validated, patient-centered instrument, developed with the largest participant group to date, offering a comprehensive assessment of HRQoL in patients with AF. Its unique strengths include extensive patient involvement, high reliability, and sensitivity to clinical interventions, making it a valuable tool for both clinical practice and research in enhancing the measurement of HRQoL in AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationQuality of LifePatient Reported Outcome MeasuresHumansMaleFemalePsychometricsProspective StudiesMiddle AgedReproducibility of ResultsAgedSurveys and QuestionnairesUnited Kingdom

Stichwörter der Autor:innen

Atrial fibrillationHealth-related quality of lifePatient reported outcome measuresPatient-centeredValidated questionnaire

Autor:innen und Institutionen

  • St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; OneWelbeck Healthcare, London, United Kingdom; William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; OneWelbeck Healthcare, London, United Kingdom; William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. Elect…

Zitieren

APA

Kanthasamy, V., Schilling, R. J., Horan, S., Baker, V., Ahluwalia, N., Hunter, R. J., Honarbakhsh, S., & Finlay, M. (2025). Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire. Heart Rhythm, 22(8), 1922-1934. https://doi.org/10.1016/j.hrthm.2025.02.007

Vancouver

Kanthasamy V, Schilling RJ, Horan S, Baker V, Ahluwalia N, Hunter RJ, et al. Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire. Heart Rhythm. 2025;22(8):1922-1934. doi:10.1016/j.hrthm.2025.02.007

BibTeX
@article{Kanthasamy2025,
  author = {Kanthasamy, Vijayabharathy and Schilling, Richard J and Horan, Sarah and Baker, Victoria and Ahluwalia, Nikhil and Hunter, Ross J and Honarbakhsh, Shohreh and Finlay, Malcolm},
  title = {Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire},
  journal = {Heart Rhythm},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {1922--1934},
  doi = {10.1016/j.hrthm.2025.02.007}
}
Kostenlos starten →